Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
A District Judge overturned last year's jury verdict, declaring the application of Teva's patents overly broad.
A District Judge overturned last year's jury verdict, declaring the application of Teva's patents overly broad.